ACCELERON PHARMA INC (XLRN) has 121 open-market insider trades by 21 insiders since 2013. The most active filer is Kevin F. McLaughlin, CFO & VP +1.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Celgene Corp. /de/ | 10% Owner | — | 8 | $172.6M | 2020-07-09 |
| Jean George | Dir | — | 8 | $119.8M | 2020-01-22 |
| Terrance McGuire | Dir | — | 3 | $27.9M | 2017-03-02 |
| Kevin F. McLaughlin | CFOVPTreasurer | — | 21 | $25.1M | 2021-11-19 |
| Habib J. Dable | CEOPres | — | 8 | $19.5M | 2021-11-19 |
| John L. Knopf | CEOPres | — | 9 | $16.6M | 2016-11-09 |
| Polaris Venture Partners IV L.P. | 10% | — | 1 | $13.4M | 2014-06-02 |
| Edwin M. Kania Jr. | Dir | — | 2 | $11.3M | 2014-12-23 |
| John D. Quisel | VP | — | 12 | $6.5M | 2020-01-02 |
| Ravindra Kumar | CSOVP | — | 10 | $4.9M | 2019-09-10 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Sujay Kango | CCO & VP | Sell | $875K | 2021-09-27 |
| Kevin F. McLaughlin | CFO & VP +1 | Sell | $8.0M | 2021-09-23 |
| Sujay Kango | CCO & VP | Sell | $750K | 2021-09-21 |
| Adam M. Veness | CLO & VP +1 | Sell | $2.0M | 2021-09-21 |
| Adam M. Veness | CLO & VP +1 | Sell | $184K | 2021-09-08 |
| Habib J. Dable | CEO & President | Sell | $22.4M |
Companies that share insiders with XLRN, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2021-07-01 |
| Thomas A. McCourt | Director | Sell | $1.8M | 2021-04-19 |
| Karen L. Smith | Director | Sell | $3.3M | 2021-04-05 |
| Joseph S. Zakrzewski | Director | Sell | $2.7M | 2021-04-05 |
| Karen L. Smith | Director | Sell | $2.4M | 2021-04-01 |
| Joseph S. Zakrzewski | Director | Sell | $2.4M | 2021-04-01 |
| Sujay Kango | CCO & VP | Sell | $1.3M | 2021-03-02 |
| Adam M. Veness | CLO & VP +1 | Sell | $252K | 2021-01-05 |
| Habib J. Dable | CEO & President | Sell | $609K | 2021-01-05 |
| Sujay Kango | CCO & VP | Sell | $2.5M | 2021-01-04 |